Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Dalian Kingport Group is a diversified Chinese healthcare conglomerate based in Dalian, Liaoning Province. The company operates primarily through its subsidiary, Dalian Kingport Pharmaceutical, which specializes in the research, development, and manufacturing of pharmaceutical products, including recombinant human insulin, cardiovascular drugs, and traditional Chinese medicines. Kingport is recognized for its large-scale production facilities and its role as a key player in the regional pharmaceutical industry. The group also has interests in medical devices and healthcare services, aiming to provide integrated health solutions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Dalian Kingport Group.